IP Library Granted Patent US 11,690,738
Granted Patent B2
US 11,690,738 · App. 16/768,286 · Granted Jul 4, 2023

Stent and preparation method therefor

Inventors: Li Qin (Shenzhen, CN); Wenjiao Lin (Shenzhen, CN)
Assignee: Biotyx Medical (Shenzhen) Co., Ltd.
A61F2/82A61F2002/91583A61F2240/001A61F2250/0098
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,690,738
App. No.
16/768,286
Granted
Jul 4, 2023
Kind
B2
Abstract

A stent and a preparation method therefor. The stent includes a stent substrate. The stent substrate is provided with at least one radiopaque structure thereon. Each radiopaque structure includes at least one radiopaque unit. A radiopaque material is inlaid in each radiopaque unit, and a ratio of the volume of the radiopaque material to the volume of the radiopaque unit ranges from 1.1 to 1.4. By the stent and the preparation method therefor, the interference fit between the radiopaque material and the radiopaque unit can be better implemented, so that the radiopaque material and the radiopaque unit have strong bonding force therebetween, and the problem of embolism caused by the drop of a radiopaque material is avoided.

Claims (11)

1. A stent, comprising:

a stent substrate, the stent substrate provided with at least one radiopaque structure thereon, and each of the radiopaque structures comprises at least one radiopaque unit, and a radiopaque material is inlaid in each of the radiopaque units; and a ratio of the volume of the radiopaque material to the volume of the radiopaque unit is 1.1 to 1.4,

wherein each of the radiopaque structures consists of four radiopaque units, the four radiopaque units being arranged in a petal shape.

2. The stent according to claim 1 , wherein a ratio of the volume of the radiopaque material to the volume of the radiopaque unit is 1.2 to 1.4.

3. The stent according to claim 1 , further comprising two radiopaque structures which are respectively disposed at two ends of the stent substrate.

4. The stent according to claim 1 , wherein the radiopaque material is selected from at least one of a group consisting of gold, platinum, osmium, rhenium, tungsten, iridium, rhodium, tantalum, barium sulfate, niobium trioxide, titanium oxide, zirconia, elemental iodine, and iodide.

5. The stent according to claim 1 , wherein each radiopaque material further comprises a binder, and the binder is a degradable polymer.

6. The stent according to claim 1 , wherein the wall thickness of the stent substrate is less than or equal to 150 microns.

7. The stent according to claim 1 , wherein the wall thickness of the stent substrate is less than or equal to 70 microns.

8. The stent according to claim 1 , wherein a projection area of radiopaque material in an X-ray incident direction is less than or equal to 0.5 mm 2 .

9. The stent according to claim 1 , wherein the radiopaque material has a cylindrical shape.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2021
From: LIFETECH SCIENTIFIC (SHENZHEN) CO., LTD
To: BIOTYX MEDICAL (SHENZHEN) CO., LTD.
Reel/Frame 055535/0106 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2020
From: QIN, LI; LIN, WENJIAO
To: LIFETECH SCIENTIFIC (SHENZHEN) CO., LTD
Reel/Frame 052800/0511 →
Priority Claims (1)
CN 201711277320.1 · Dec 6, 2017 · national
Continuity (1)
Related Publication 20200289297A1 · Sep 17, 2020